Evolving IO Management Strategies in Cutaneous Squamous Cell Carcinoma

Vishal Patel, MD, FAAD, FACMS, discusses the importance of multidisciplinary care for patients with locally advanced or unresectable CSCC.

explains how the availability of neoadjuvant and adjuvant immunotherapy is reshaping treatment decisions in CSCC.

Sunandana Chandra, MD, discusses the current systemic treatment landscape for patients with unresectable, locally advanced, or metastatic cutaneous squamous cell carcinoma.

Sunandana Chandra, MD, MS, discusses how resectability, anatomy, prior therapy, and patient fitness guide multidisciplinary treatment decisions in CSCC.

Drs Whitman and Patel discuss the evolving treatment paradigm for patients with CSCC, emphasizing the role of neoadjuvant and adjuvant immunotherapies.